L-Arginine Hydrochloride

L-Arginine Hydrochloride, an amino acid supplement, is being studied in clinical trials for its potential benefits in various medical conditions. This article explores two significant studies: one investigating its role in preventing kidney problems after heart surgery, and another examining its safety and effectiveness in treating severe malaria. These trials aim to provide valuable insights into how L-Arginine Hydrochloride might improve patient outcomes in these challenging medical scenarios.

Table of Contents

What is L-Arginine Hydrochloride?

L-Arginine Hydrochloride is a form of the amino acid arginine that is being studied for its potential therapeutic effects in various medical conditions. Amino acids are the building blocks of proteins in our body. L-Arginine is considered a “conditionally essential” amino acid, meaning that while our body can produce it, we may need more from our diet or supplements under certain conditions or illnesses.[1][2]

Potential Uses of L-Arginine Hydrochloride

Research is ongoing to explore the potential benefits of L-Arginine Hydrochloride in different medical conditions. Two main areas of study include:

  • Cardiac Surgery: Investigating its role in preventing kidney problems after heart surgery[1]
  • Severe Malaria: Exploring its potential to improve outcomes in patients with severe malaria[2]

L-Arginine in Cardiac Surgery

One clinical trial is studying the use of L-Arginine Hydrochloride in patients undergoing cardiac surgery that requires cardiopulmonary bypass (CPB). CPB is a technique that temporarily takes over the function of the heart and lungs during surgery. The main focus of this study is to see if L-Arginine can help prevent a condition called Cardiac Surgery-Associated Acute Kidney Injury (CSA-AKI).[1]

Acute Kidney Injury (AKI) is a sudden decrease in kidney function. In this study, researchers are looking at whether giving L-Arginine soon after surgery can reduce the chances of developing AKI. They measure this by checking:

  • Changes in blood creatinine levels (a waste product normally filtered by the kidneys)
  • Urine output (how much urine a patient produces)

The researchers are also interested in seeing if L-Arginine can reduce the severity of AKI if it does occur, lower the risk of death in the hospital, and shorten the length of hospital stay.[1]

L-Arginine in Severe Malaria

Another clinical trial is investigating the use of L-Arginine Hydrochloride in patients with severe falciparum malaria. Falciparum malaria is a serious form of malaria caused by a parasite called Plasmodium falciparum. Even with the best available treatments, about 15% of patients with severe malaria do not survive.[2]

The researchers believe that L-Arginine might help improve outcomes in severe malaria by:

  • Improving endothelial function (the health of the lining of blood vessels)
  • Helping the body clear lactate (a substance that can build up during severe illness) more quickly
  • Improving oxygen delivery to tissues

The study is also looking at several other effects of L-Arginine, including its impact on fever, the clearance of malaria parasites from the blood, and various markers of blood vessel health.[2]

How is L-Arginine Administered?

In both studies, L-Arginine Hydrochloride is given as an intravenous (IV) infusion, which means it’s delivered directly into the bloodstream through a vein. The dosage and duration of the infusion vary depending on the study:

  • In the cardiac surgery study, L-Arginine is given in the early stages after surgery, before any signs of kidney injury appear.[1]
  • In the malaria study, different doses and durations are being tested:
    • 12 grams over 8 hours
    • 24 grams over 8 hours
    • 1.5 grams per hour for 24 hours (total of 36 grams)

These different regimens are being tested to find the most effective and safe way to use L-Arginine.[2]

Safety Considerations

Both studies are carefully monitoring the safety of L-Arginine Hydrochloride. This includes checking for any side effects or unexpected reactions. In the malaria study, researchers are particularly interested in how L-Arginine affects blood pressure and other vital signs, as well as various blood tests to check organ function.[2]

It’s important to note that these are ongoing clinical trials, and L-Arginine Hydrochloride is not yet approved for routine use in these conditions. Patients should not attempt to use L-Arginine on their own for these purposes without medical supervision.

Aspect Heart Surgery Study Severe Malaria Study
Main Condition Acute Kidney Injury after cardiac surgery Severe Falciparum Malaria
L-Arginine Administration Early postoperative stage 8-hour or 24-hour infusion
Primary Outcome Incidence of postoperative AKI Improvement in endothelial function and lactate clearance
Secondary Outcomes Severity of AKI, mortality, hospital stay length Safety, changes in various clinical and biochemical measures
Study Design Comparison of groups with and without L-Arginine Randomized controlled trial comparing L-Arginine to saline placebo

Ongoing Clinical Trials on L-Arginine Hydrochloride

  • Study to Find the Right Dose and Safety of Lutetium (177Lu) Edotreotide and Arginine-Lysine in Children with Somatostatin Receptor-Positive Tumors

    Recruiting

    1 1
    France Italy Spain
  • Study on RYZ101 for Patients with Advanced Gastroenteropancreatic Neuroendocrine Tumors After Previous Treatment

    Recruiting

    1 1 1 1
    Belgium France The Netherlands Spain
  • Study on Retreatment with Lutetium (177Lu) Oxodotreotide for Patients with Intestinal Neuroendocrine Tumors

    Recruiting

    1 1 1
    France
  • Study on the Safety and Effectiveness of [90Y]Y-PentixaTher in Patients with Recurrent or Resistant CNS Lymphoma

    Recruiting

    1 1 1
    Investigated diseases:
    Germany
  • Study of Lutetium (177Lu) Oxodotreotide for Children with Relapsed or Refractory High-Risk Neuroblastoma

    Recruiting

    1 1 1
    Investigated diseases:
    Denmark Lithuania The Netherlands Norway Spain Sweden
  • Study Comparing 177Lu-Edotreotide and Everolimus for Patients with Neuroendocrine Tumors in the Lung and Thymus

    Recruiting

    1 1 1 1
    Belgium France Italy Spain
  • Study on the Effectiveness of Lutetium (177Lu) Oxodotreotide and Octreotide in Patients with Advanced GEP-NET Tumors (Grade 2 and 3)

    Not recruiting

    1 1 1 1
    Investigated diseases:
    France Germany Italy The Netherlands Spain
  • Study comparing 177Lu-edotreotide versus everolimus in patients with inoperable progressive neuroendocrine tumors of gastroenteric or pancreatic origin

    Not recruiting

    1 1 1 1
    Austria Belgium Czechia France Germany Italy +3
  • Study on the Safety of Lutetium (177Lu) Oxodotreotide, L-Lysine Hydrochloride, and L-Arginine Hydrochloride in Adolescents with Neuroendocrine Tumors and PPGLs

    Not recruiting

    1 1 1
    Investigated diseases:
    France Poland Spain
  • Study of Lutetium (177Lu) Edotreotide compared to standard treatment in patients with aggressive Grade 2 and Grade 3 gastroenteropancreatic neuroendocrine tumors (GEP-NETs)

    Not recruiting

    1 1 1 1
    France Germany Italy The Netherlands Spain

Glossary

  • Acute Kidney Injury (AKI): A sudden decrease in kidney function, which can happen after major surgery or in severe illnesses. It's diagnosed by measuring changes in urine output and blood tests.
  • Cardiopulmonary Bypass (CPB): A technique used in some heart surgeries where a machine temporarily takes over the function of the heart and lungs during the operation.
  • Endothelial Function: The health and performance of the inner lining of blood vessels, which is important for proper blood flow and organ function.
  • Falciparum Malaria: A severe form of malaria caused by a specific parasite. It can be life-threatening if not treated promptly.
  • Lactate Clearance: The rate at which the body removes lactate from the blood. High lactate levels can indicate poor oxygen delivery to tissues.
  • Oliguria: A condition where the body produces an abnormally small amount of urine, which can be a sign of kidney problems.
  • Pharmacokinetics: The study of how a drug moves through the body, including how it's absorbed, distributed, and eliminated.
  • Pharmacodynamics: The study of how a drug affects the body, including its mechanism of action and the body's response to the drug.

References

  1. https://clinicaltrials.gov/study/NCT06248359
  2. https://clinicaltrials.gov/study/NCT00616304